AI Summary
Certain nano-based cancer therapies may be less effective in younger patients due to the more efficient ability of their livers to filter the bloodstream, which filters out beneficial treatments. This highlights the need for further investigation into the impact of aging on the body's response to treatment.
Researchers have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body’s ability to respond to treatment. The researchers found age-related differences are due to how effectively the liver filters the bloodstream. Younger livers are more efficient at this process, which helps limit toxins in the blood but also filters out beneficial treatments, potentially rendering them ineffective.